1 minute read

A.B. Baker Award Recipient Addresses ‘Going Back to Basics’

David M. Greer, MD, MA, FAAN

A.B. Baker Award for Lifetime Achievement in Neurological Education recipient, David M. Greer, MD, MA, FAAN, will treat Annual Meeting attendees to a compelling keynote address on Neurology Education: What’s Old is New Again today at 1:00 p.m. in the Academic Exchange Learner Engagement Center in Tahoma 1. The professor and chair of neurology at Boston University Medical Center will share persuasive insights and reasons to go back to basics, explaining that the personal connection with the learner remains central to everything we do in education.

The A.B. Baker Award recognizes national accomplishment in the field of neurologic education, with the awardee not only demonstrating leadership and devotion to neurologic education, but also someone who has published widely and influenced generations of trainees. “Dr. Greer has had an illustrious career as a clinician, researcher, and educator,” said Dara V. Albert, DO. “He has held such esteemed leadership roles in education as the program director of the combined neurology residency at Harvard, program director at Yale, and is currently the neurologist-in-chief at Boston Medical Center. He has received regional, national, and international awards and recognition as an educator and has clearly had a significant and lasting impact on neurology.” “I am so very grateful and thankful to the AAN, as well as my many wonderful mentors, including Dr. Marty Samuels, Dr. Ralph Sacco, and most of all, my late father, (past AAN president, 1985-1987) Dr. Melvin Greer,” said Greer. “I also thank all of my students, residents, fellows and faculty, for teaching me far more than I ever taught them.” Funded by an endowment created by matching funds from the A.B. Baker Family Trust and Novartis Pharmaceuticals. 

SUPPORTING PATIENTS WITH LEMS IN EVERY WAY WE CAN

The right treatment and support go hand in hand

Catalyst Pharmaceuticals created Catalyst Pathways®, a free, personalized program designed to help you and your adult patients manage the unique challenges of Lambert-Eaton myasthenic syndrome (LEMS) through:

One-on-one support and education Financial support programs

A dedicated team of specialists to navigate insurance Patient Mentor Program

Find out more about all the ways Catalyst Pharmaceuticals is working to help support you and your patients.

To learn more, visit YourCatalystPathways.com.

This article is from: